+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)


Moberg Pharma AB (MOB) - Financial and Strategic SWOT Analysis Review

1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.


Moberg Pharma AB (Moberg Pharma), formerly Moberg Derma AB is a pharmaceutical company that offers medical products for the treatment of skin diseases. The company offers products which include Emtrix, Nalox and Naloc, Kerasal nail, Kerasal foot ointment, Domeboro, Blamex and Balmex adult care. It offers Kerasal nail for discolored and fungus-damaged nails and Kerasal foot ointment for dry and cracked heels. Moberg Pharma's Domeboro is used for treatment of minor skin irritations. The company works in collaboration to develop Oral mucositis for the treatment of pain in the oral cavity. It markets its products in Europe, South America, Africa, the Middle East and others. Moberg Pharma is headquartered in Stockholm, Sweden.

Moberg Pharma AB Key Recent Developments

Feb 13, 2018: Moberg Pharma Year-end Report 2017
Nov 30, 2017: Moberg Pharma Reorganizes its Commercial Operations
Nov 13, 2017: Moberg Pharma interim report January - September 2017
Sep 22, 2017: Addition to Moberg Pharma´s management team
Aug 08, 2017: Moberg Pharma: interim report January- June 2017

This comprehensive SWOT profile of Moberg Pharma AB provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of the author’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, the author’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Moberg Pharma AB including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including:
  • Business description - A detailed description of the company’s operations and business divisions.
  • Corporate strategy - Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief summary of the executives’ employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities - A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
*Note: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Product cover images may vary from those shown
Section 1 - About the Company
  • Moberg Pharma AB - Key Information
  • Moberg Pharma AB - Overview
  • Moberg Pharma AB - Key Employees
  • Moberg Pharma AB - Key Employee Biographies
  • Moberg Pharma AB - Key Operational Heads
  • Moberg Pharma AB - Major Products and Services
  • Moberg Pharma AB - History
  • Moberg Pharma AB - Company Statement
  • Moberg Pharma AB - Locations And Subsidiaries
  • Moberg Pharma AB - Key Manufacturing facilities
  • Head Office
  • Other Locations & Subsidiaries
Section 2 - Company Analysis
  • Moberg Pharma AB - Business Description
  • Moberg Pharma AB - Corporate Strategy
  • Moberg Pharma AB - SWOT Analysis
  • SWOT Analysis - Overview
  • Moberg Pharma AB - Strengths
  • Moberg Pharma AB - Weaknesses
  • Moberg Pharma AB - Opportunities
  • Moberg Pharma AB - Threats
  • Moberg Pharma AB - Key Competitors
Section 3 - Company Financial Performance Charts
  • Moberg Pharma AB - Financial Ratios
  • Financial Ratios - Capital Market Ratios
  • Financial Ratios - Annual Ratios
  • Financial Ratios - Interim Ratios
  • Financial Ratios - Ratio Charts
Section 4 - Appendix
  • Appendix
  • Methodology
  • Ratio Definitions
  • About
  • Contact
  • Disclaimer
*Note: Some sections may be missing if data is unavailable for the company

List of Tables
  • Moberg Pharma AB, Key Information
  • Moberg Pharma AB, Key Ratios
  • Moberg Pharma AB, Share Data
  • Moberg Pharma AB, Major Products and Services
  • Moberg Pharma AB, History
  • Moberg Pharma AB, Key Employees
  • Moberg Pharma AB, Key Employee Biographies
  • Moberg Pharma AB, Key Operational Heads
  • Moberg Pharma AB, Other Locations
  • Moberg Pharma AB, Subsidiaries
  • Moberg Pharma AB, Key Manufacturing facilities
  • Moberg Pharma AB, Key Competitors
  • Moberg Pharma AB, SWOT Analysis
  • Moberg Pharma AB, Ratios based on current share price
  • Moberg Pharma AB, Annual Ratios
  • Moberg Pharma AB, Interim Ratios
  • Currency Codes
  • Capital Market Ratios
  • Equity Ratios
  • Profitability Ratios
  • Cost Ratios
  • Liquidity Ratios
  • Leverage Ratios
  • Efficiency Ratios
List of Figures
  • Moberg Pharma AB, Performance Chart
  • Moberg Pharma AB, Ratio Charts
Note: Product cover images may vary from those shown